Consult a qualified provider before use
Most peptides obtained outside of a clinical trial or compounding pharmacy setting cannot be guaranteed sterile, pure, or bioactive. CSMR, 2018 Risks of Injecting an Unregulated Compound Patients often reconstitute BPC157 at home using bacteriostatic water (often purchased separately), without understanding: Sterile technique standards are not being met
Comparison guides like BPC-157 vs TB-500 , semaglutide vs tirzepatide , and Ipamorelin vs CJC-1295 help select between similar options when building stacks
Contraindications and precautions Consider avoiding DSIP or consulting a physician if: Pregnant or breastfeeding (insufficient safety data) Taking naloxone or other opioid antagonists (may block effects) Using medications metabolized by peptidases (potential interactions) History of immune disorders (theoretical immunogenicity concern) Already using multiple sleep medications Drug interactions Because DSIP degrades via amino-peptidases in blood, medications affecting these enzymes (like the ACE inhibitor captopril) could theoretically alter DSIP metabolism
BPC-157 reportedly induced increased levels of phosphorylation of both PAK and paxillin, while the total protein level remained unchanged